Asia-Pacific Americas Africa Europe Middle East

MOREPEN LABRORATORIES LTD

Company Profile:

MOREPEN LABORATORIES LTD

Classification: Manufacturer

Morepen Laboratories Ltd. is an Indian pharmaceutical company primarily engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), finished dosages, and various consumer healthcare products. The company operates state-of-the-art manufacturing facilities and is a significant player in the pharmaceutical industry, focusing on research, development, and production of a wide range of healthcare solutions.

Enterprise Products



Products Manufactured or Sold:

Active Pharmaceutical Ingredients (APIs) such as Loratadine, Montelukast, Atorvastatin, Fexofenadine, Rosuvastatin, Silodosin, Olmesartan, Clopidogrel, Rupatadine, and a wide range of other bulk drugs used in various therapeutic segments.

Finished Dosage Formulations (Branded and Generic Drugs) covering therapeutic areas including antihistamines, cardiovascular medicines, anti-diabetics, pain management, gastrointestinal drugs, and anti-infectives.

Over-the-Counter (OTC) and Consumer Healthcare Products including established brands like Burnol antiseptic cream and Lemolate for cold and flu relief. The Dr. Morepen brand offers a comprehensive portfolio of health and wellness products such as blood glucose monitors (GlucoOne), blood pressure monitors (BP One), digital thermometers, nebulizers, face masks, hand sanitizers, and a variety of dietary supplements including multivitamins, protein supplements, omega-3 fatty acids, and calcium.

Medical Devices and Diagnostics including blood glucose monitoring systems, blood pressure monitors, and digital thermometers for personal and home healthcare use.

Business Registration Information:

Manager:

Mr. Sushil Suri

Phone:

+91-124-4366600

E-mail:

investors@morepen.com

Official Website:
Address:

Morepen House Plot No. 464 Udyog Vihar Phase-III Gurgaon - 122016 Haryana, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.